Delivery of adjuvant chemotherapy (AC) to veterans with resected colon cancer

Simple item page
dc.contributor.authorRiggs, Heather D.
dc.contributor.authorLane, Kathleen A.
dc.contributor.authorLoehrer, Patrick J.
dc.contributor.authorHui, Sui
dc.contributor.authorRawl, Susan M.
dc.contributor.authorOrmerod, Anne
dc.contributor.authorWeiner, Michael
dc.date.accessioned2014-05-03T23:36:58Z
dc.date.available2014-05-03T23:36:58Z
dc.date.issued2012-06
dc.description.abstractPatients with incomplete administration of AC for colon cancer (CC) likely experience inferior survival while oxaliplatin- and capecitabine-containing AC may not improve survival for older patients. The influence on AC completion of age, other baseline patient characteristics, or regimen characteristics is unknown. We evaluated the association of baseline characteristics and planned AC regimen with AC delivery in resected CC patients.en_US
dc.identifier.citationRiggs, H., Lane, K., Loehrer, P., Hui, S., Rawl, S., Ormerod, A., Weiner, M. (2012). Delivery of adjuvant chemotherapy to veterans with resected colon cancer. [Abstract published in the Proceedings of the 2012 ASCO Annual Meeting, June, 2012.] J Clin Oncol 30, 2012. (Suppl; abstr e16557).en_US
dc.identifier.urihttps://hdl.handle.net/1805/4407
dc.language.isoen_USen_US
dc.publisherASCO Annual Meetingen_US
dc.subjectColon canceren_US
dc.subjectVeteransen_US
dc.subjectChemotherapyen_US
dc.subjectHealth services researchen_US
dc.titleDelivery of adjuvant chemotherapy (AC) to veterans with resected colon canceren_US
dc.typeOtheren_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
riggs-2012-delivery.pdf
Size:
22.34 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
IU School of Nursing Works